Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases.
Champlin
R
R
Department of Blood and Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston 77030, USA. rchampli@mdacc.tmc.edu
Khouri
I
I
Giralt
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006087:Graft vs Host Reaction; D020350:Graft vs Tumor Effect; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D010865:Pilot Projects; D012008:Recurrence; D012074:Remission Induction; D016176:T-Lymphocyte Subsets / Q000276:immunology; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous